John Langenfeld, MD
- Director, Thoracic Oncology Program
- Thoracic Surgeon
To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
Please read our guidelines before visiting Rutgers Cancer Institute. | COVID-19: What Cancer Patients Should Know
4.6
(32 reviews)
4.6
(32 reviews)
To schedule a new patient appointment call 844-CANCERNJ (844-226-2376)
To schedule a follow-up appointment call 732-235-7615
For all other inquiries call 732-235-2465.
Since coming to Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School in 1999 I have devoted my career to improve the survival of patients with lung and esophagus cancers. Building on my clinical experience from Memorial Sloan-Kettering Cancer Center I have established a center of excellence to treat patients with thoracic malignancies. Our success has been from a collaborative effort with Robert Wood Johnson University Hospital to provide an outstanding thoracic surgery program, which includes superior nursing and a broad range of medical experts to assist in the care of patients. This team approach is reflected in our success and the positive experience of our patients.
I have also devoted myself to improve patient outcomes with ongoing research endeavors. Our center was part of a national trial, which demonstrated that CT screening for lung cancer improves survival in smokers. I have recently reported that low-dose steroids improve survival in patients who develop respiratory compromise after a pulmonary resection.
My laboratory identified that the bone morphogenetic protein 2 (BMP2), a protein expressed in embryos, is aberrantly expressed in the majority of lung cancers. The BMP2 protein enhances the growth, survival, and spread of lung cancers. My recent work suggests that novel inhibitors of this pathway represent potential new drugs to treat patients with lung cancers.
Lung cancer, esophagus cancer, tumors of the chest wall, and mediastinum, achalasia, hyperhidrosis, and pectus excuvatum.
4.6 Overall
Based on 32 reviews
Provider explained things clearly
Provider showed concern
Provider included you in decisions
Likelihood of recommending this provider
Provider discussed treatment options
October 4, 2024
Dr. Langenfeld & staff are graded A+ - TOP NOTCH!
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with your insurance company they are still a participating plan prior to receiving services or care. Each plan is different and some provide different levels of coverage that could make a difference in your out-of-pocket costs. It is always best for the patient receiving care to contact their insurance company to obtain more information.